CODOX-M/IVAC-R versus DA-EPOCH-R in double hit/triple hit lymphoma patients aged 60 years or under.

https://read.qxmd.com/read/39385736/codox-m-ivac-r-versus-da-epoch-r-in-double-hit-triple-hit-lymphoma-patients-aged-60-years-or-under?uac=148436CN&ecd=wnl_readmost_250117&sso=true&redirected=slug